Would you perform surgery after only reading about it? Trading live on an untested idea is the same wager. Backtesting — rehearsing your exact rules against historical price — is how an idea earns the right to touch money.
Manual replay beats fantasy scrolling
Scrolling a finished chart and cherry-picking wins is not testing; hindsight marks every exam. Use bar-replay (TradingView has it): hide the future, step candle by candle, and log every decision as if live — entry, stop, target, and the confluences present, written before advancing. Slow is the feature: your eyes learn the setup while the sample builds.
The honesty rules
- Define rules first, in writing — testing "vibes" produces vibes.
- Take every qualifying setup, including ugly ones; skipping in-sample losers is self-deception with extra steps.
- Charge costs: subtract realistic spread from each result; scalping ideas regularly die at this step alone.
- Log in R so results feed straight into an expectancy calculation.
- One market, one timeframe per test — isolate the variable.
What a sample proves — and doesn't
Fifty to a hundred replayed trades showing positive expectancy proves the idea deserved a demo trial — not that it's holy. Markets shift; live spreads bite; your live psychology differs from replay calm. The pipeline is: backtest → demo (30+ compliant trades) → small live. Each stage filters; most ideas rightly die early — which is the cheapest place for them to die.
Rehearsal is respect for your capital. The market charges full tuition to everyone who skips it.
Education only — not financial advice. Trading carries risk of loss; never trade money you cannot afford to lose.
